Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus causing acute respiratory tract infection in humans. The virus has the characteristics of rapid transmission, long incubation period and strong pathogenicity, and has spread all over the world. Therefore, it is of great significance to select appropriate animal models for antiviral drug development and therapeutic effect evaluation. Here, we review and compare the current animal models of SARS-CoV-2.
All Keywords
【저자키워드】 COVID-19, SARS-CoV-2, Pathogenesis, animal model, ACE2 (angiotensin converting enzyme 2), 【초록키워드】 coronavirus, respiratory tract infection, Transmission, virus, antiviral drug, Novel coronavirus, Spread, Characteristics, humans, Incubation period, pathogenicity, acute respiratory syndrome, therapeutic effect, 【제목키워드】 ferret, mink, animal, Model, mouse, tree, primate, Non-human, Shrew,
【저자키워드】 COVID-19, SARS-CoV-2, Pathogenesis, animal model, ACE2 (angiotensin converting enzyme 2), 【초록키워드】 coronavirus, respiratory tract infection, Transmission, virus, antiviral drug, Novel coronavirus, Spread, Characteristics, humans, Incubation period, pathogenicity, acute respiratory syndrome, therapeutic effect, 【제목키워드】 ferret, mink, animal, Model, mouse, tree, primate, Non-human, Shrew,